Dr. Phillip Kim, MD

Dr. Kim practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Kim's NPI, 1649775313, was assigned on March 26, 2018. Dr. Kim graduated from Wake Forest School of Medicine in 2018. Dr. Kim's Texas license number on file is V3351.

Dr. Kim's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Kim's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Kim is also affiliated with South Texas Health System Edinburg. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Kim to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kim is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Kim's licenses on file in 3 states: Texas, Massachusetts and California.

Dmand AI lists kidney stone disease, transurethral procedures and urinary endoscopy among the conditions Dr. Kim treats.

CMS data shows 29 Medicare services from Dr. Kim across 2 procedure codes in 2024, all of them office visits, for 48 Medicare patients. Medicare paid $2,017 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 48 Medicare patients who saw Dr. Kim in 2024. The largest group is 65 to 74, with 24 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 67, with 29% women.

In 2024, Dr. Kim wrote 49 Medicare Part D claims for 27 patients. 100% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $477 in total drug cost. In 2023, CMS named 168 claims across 6 drugs.

Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of prostate resection by Dr. Kim, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Kim, published from 2012 to 2024. 2016 was the busiest year, with 2. The most frequent topics are Diagnosis, Differential and Kidney Neoplasms. Dr. Kim's most frequent co-authors are Brian Burns Ghoshhajra, MD, Harshna V. Vadvala, MBBS and Suhny Abbara, MD.

CMS Open Payments shows 11 general payments to Dr. Kim from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $360.

Dr. Kim graduated from Wake Forest School of Medicine in 2018.

Dr. Kim is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.